SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041842
Filing Date
2021-08-12
Accepted
2021-08-12 10:39:29
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_bioessencecorp.htm   iXBRL 10-Q 643078
2 CERTIFICATION f10q0621ex31-1_bioessence.htm EX-31.1 23192
3 CERTIFICATION f10q0621ex32-1_bioessence.htm EX-32.1 11738
4 GRAPHIC img_001.jpg GRAPHIC 11410
5 GRAPHIC img_002.jpg GRAPHIC 118794
  Complete submission text file 0001213900-21-041842.txt   4385497

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cik00001723059-20210630.xsd EX-101.SCH 50765
7 XBRL CALCULATION FILE cik00001723059-20210630_cal.xml EX-101.CAL 43725
8 XBRL DEFINITION FILE cik00001723059-20210630_def.xml EX-101.DEF 199001
9 XBRL LABEL FILE cik00001723059-20210630_lab.xml EX-101.LAB 391482
10 XBRL PRESENTATION FILE cik00001723059-20210630_pre.xml EX-101.PRE 206882
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_bioessencecorp_htm.xml XML 459176
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 211165970
SIC: 2834 Pharmaceutical Preparations